Lung Cancer Trial, Recruiting (NCT06082492)

Lung Cancer Trial, Recruiting NCT06082492 Sponsor: Radboud University Medical Center Condition: Lung Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06082492 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lung Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with stage III non-small cell lung cancer (a specific type and stage of lung cancer), confirmed by a tissue or cell sample taken before your main treatment began
You have completed or are currently undergoing treatment aimed at curing your cancer, and have started your follow-up care
Any additional treatments given after your main treatment (such as immunotherapy or chemotherapy) are allowed during the study
You are 18 years of age or older
You are reasonably able to carry out daily activities — not completely disabled by your illness (confirm with trial site)
You are able and willing to give written, signed agreement to take part, and understand you can withdraw at any time without it affecting your future care

Who may not be able to join:

Doctors expect you to live for less than 6 months after finishing your main cancer treatment
There are signs that your cancer has come back after finishing your main treatment and before you are enrolled into the study
You have any other condition that, in the doctor's judgement, might interfere with the study results or how your quality of life is measured (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 30 June 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06082492

Sponsor: Radboud University Medical Center

Phase: Not Applicable

Status: Recruiting

Condition: Lung Cancer

More information: https://clinicaltrials.gov/study/NCT06082492

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with stage III non-small cell lung cancer (a specific type and stage of lung cancer), confirmed by a tissue or cell sample taken before your main treatment began
You have completed or are currently undergoing treatment aimed at curing your cancer, and have started your follow-up care
Any additional treatments given after your main treatment (such as immunotherapy or chemotherapy) are allowed during the study
You are 18 years of age or older
You are reasonably able to carry out daily activities — not completely disabled by your illness (confirm with trial site)
You are able and willing to give written, signed agreement to take part, and understand you can withdraw at any time without it affecting your future care

Who may not be able to join:

Doctors expect you to live for less than 6 months after finishing your main cancer treatment
There are signs that your cancer has come back after finishing your main treatment and before you are enrolled into the study
You have any other condition that, in the doctor's judgement, might interfere with the study results or how your quality of life is measured (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 30 June 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Radboud University Medical Center

Registry

ClinicalTrials.gov

Start date

19 March 2024

Est. completion

1 April 2029

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Overall Survival (OS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov